Primary Sclerosing Cholangitis (PSC) Clinical Trial
Official title:
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase Like 2 (LOXL2) in Subjects With Primary Sclerosing Cholangitis (PSC)
The purpose of this study is to evaluate whether simtuzumab (GS-6624) is effective at preventing the progression of liver fibrosis in adults with primary sclerosing cholangitis (PSC).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05082779 -
Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS0159
|
Phase 1 | |
| Completed |
NCT06037577 -
Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects
|
Phase 1 | |
| Completed |
NCT02061540 -
Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis
|
Phase 2 | |
| Completed |
NCT01819766 -
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
|
N/A | |
| Active, not recruiting |
NCT01161992 -
Genomics of Primary Sclerosing Cholangitis (PSC)
|
||
| Completed |
NCT02808312 -
Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function
|
Phase 1 | |
| Completed |
NCT03333928 -
A POC and Dose-Ranging Study of HTD1801 in PSC Patients
|
Phase 2 | |
| Completed |
NCT02177136 -
Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)
|
Phase 2 | |
| Completed |
NCT03766035 -
Cholangioscopy in Primary Sclerosing Cholangitis (PSC)
|
||
| Completed |
NCT01695174 -
A Pilot Study of Xifaxan to Treat Patients With PSC
|
Phase 1 | |
| Recruiting |
NCT06026865 -
S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC)
|
N/A |